Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Research Report 2022

Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Research Report 2022

Table of Contents
1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Overview
1.1 Product Overview and Scope of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
1.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Type
1.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Serotype 6B
1.2.3 7F Serotype
1.2.4 Serotype 9V
1.2.5 14 Serotype
1.2.6 Serotype 18C
1.2.7 Serotype 19A
1.2.8 19F Serotype
1.2.9 23F Serotype
1.2.10 24F Serotype
1.2.11 Other
1.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application
1.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Comparison by Application: (2022-2028)
1.3.2 Infants from 6 Weeks to 15 Months Old
1.3.3 Children Aged 15 Months to 5 Years
1.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Estimates and Forecasts
1.4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2017-2028
1.4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2017-2028
1.4.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Region: 2017 Versus 2021 Versus 2028
2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Competition by Manufacturers
2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Manufacturers (2017-2022)
2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Sites, Area Served, Product Type
2.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Competitive Situation and Trends
2.5.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players Market Share by Revenue
2.5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario by Region
3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
3.3.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
3.3.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
3.4.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
3.4.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Region
3.5.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
3.5.2 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
3.6.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
3.6.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
3.7.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
3.7.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historic Market Analysis by Type
4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2017-2022)
4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2017-2022)
4.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Type (2017-2022)
5 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historic Market Analysis by Application
5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2017-2022)
5.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application (2017-2022)
5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Minhai Bio
6.2.1 Minhai Bio Corporation Information
6.2.2 Minhai Bio Description and Business Overview
6.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
6.2.5 Minhai Bio Recent Developments/Updates
6.3 Kexing Bio
6.3.1 Kexing Bio Corporation Information
6.3.2 Kexing Bio Description and Business Overview
6.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
6.3.5 Kexing Bio Recent Developments/Updates
6.4 Cansino Bio
6.4.1 Cansino Bio Corporation Information
6.4.2 Cansino Bio Description and Business Overview
6.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
6.4.5 Cansino Bio Recent Developments/Updates
6.5 Lanzhou Biological Preparations Institute
6.5.1 Lanzhou Biological Preparations Institute Corporation Information
6.5.2 Lanzhou Biological Preparations Institute Description and Business Overview
6.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
6.5.5 Lanzhou Biological Preparations Institute Recent Developments/Updates
7 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Cost Analysis
7.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
7.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors List
8.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customers
9 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Dynamics
9.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Trends
9.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Drivers
9.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Challenges
9.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Restraints
10 Global Market Forecast
10.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2023-2028)
10.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Application (2023-2028)
10.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Competitive Situation by Manufacturers in 2021
Table 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Sites and Area Served
Table 11. Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2017-2022) & (K Units)
Table 16. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2017-2022)
Table 17. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region (2017-2022)
Table 19. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2022) & (K Units)
Table 20. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2017-2022)
Table 21. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2017-2022)
Table 23. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2022) & (K Units)
Table 24. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2017-2022)
Table 25. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region (2017-2022)
Table 31. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2022) & (K Units)
Table 32. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2017-2022)
Table 33. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2017-2022)
Table 39. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2017-2022) & (K Units)
Table 40. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2017-2022)
Table 41. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Type (2017-2022)
Table 43. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Type (2017-2022) & (US$/Unit)
Table 44. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units) by Application (2017-2022)
Table 45. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2017-2022)
Table 46. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Application (2017-2022)
Table 48. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Application (2017-2022) & (US$/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product
Table 53. Pfizer Recent Developments/Updates
Table 54. Minhai Bio Corporation Information
Table 55. Minhai Bio Description and Business Overview
Table 56. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product
Table 58. Minhai Bio Recent Developments/Updates
Table 59. Kexing Bio Corporation Information
Table 60. Kexing Bio Description and Business Overview
Table 61. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product
Table 63. Kexing Bio Recent Developments/Updates
Table 64. Cansino Bio Corporation Information
Table 65. Cansino Bio Description and Business Overview
Table 66. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product
Table 68. Cansino Bio Recent Developments/Updates
Table 69. Lanzhou Biological Preparations Institute Corporation Information
Table 70. Lanzhou Biological Preparations Institute Description and Business Overview
Table 71. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product
Table 73. Lanzhou Biological Preparations Institute Recent Developments/Updates
Table 74. Production Base and Market Concentration Rate of Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors List
Table 77. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customers List
Table 78. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Trends
Table 79. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Drivers
Table 80. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Challenges
Table 81. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Restraints
Table 82. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Type (2023-2028) & (K Units)
Table 83. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Type (2023-2028)
Table 84. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 85. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Type (2023-2028)
Table 86. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Application (2023-2028) & (K Units)
Table 87. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Application (2023-2028)
Table 88. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 89. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Application (2023-2028)
Table 90. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2023-2028) & (K Units)
Table 91. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Region (2023-2028)
Table 92. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 93. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Region (2023-2028)
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Figure 2. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Type in 2021 & 2028
Figure 3. Serotype 6B Product Picture
Figure 4. 7F Serotype Product Picture
Figure 5. Serotype 9V Product Picture
Figure 6. 14 Serotype Product Picture
Figure 7. Serotype 18C Product Picture
Figure 8. Serotype 19A Product Picture
Figure 9. 19F Serotype Product Picture
Figure 10. 23F Serotype Product Picture
Figure 11. 24F Serotype Product Picture
Figure 12. Other Product Picture
Figure 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Application in 2021 & 2028
Figure 14. Infants from 6 Weeks to 15 Months Old
Figure 15. Children Aged 15 Months to 5 Years
Figure 16. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size (2017-2028) & (US$ Million)
Figure 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (2017-2028) & (K Units)
Figure 19. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Manufacturers in 2021
Figure 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Manufacturers in 2021
Figure 21. The Global 5 and 10 Largest 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players: Market Share by Revenue in 2021
Figure 22. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2017-2022)
Figure 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region in 2021
Figure 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region (2017-2022)
Figure 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region in 2021
Figure 27. United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. U.K. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Australia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. China Taiwan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Indonesia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Thailand 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Malaysia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Argentina 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Saudi Arabia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. UAE 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. Sales Market Share of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2017-2022)
Figure 50. Manufacturing Cost Structure of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Figure 51. Manufacturing Process Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Figure 52. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs